Evaluation of Two Levels of Frequency of Repositioning in the Reduction of Pressure Ulcers (PENFUP-2)

January 19, 2024 updated by: Olga Cortés, RN, MSc, PhD, Fundación Cardioinfantil Instituto de Cardiología

Evaluation of the Efficacy of Two Levels of Frequency of Repositioning in Adults Hospitalized in Intensive Care Units, in the Reduction of Pressure Ulcers: A Randomized Cluster Study.

PENFUP FASE 2, It is a multicenter study by parallel conglomerates, planned in order to evaluate the efficacy between two levels of frequency of postural change in intensive care units for adults of hospitals in various regions of Colombia.

Study Overview

Detailed Description

Taking into account a design effect of 6.7, Investigators planned to include 150 participants from each ICU. Investigators did calculate that a total of 22 ICUs are required, in which 11 will be assigned to the low frequency and 11 will be assigned to a high frequency group of postural change until obtaining a total of 1,650 patients in each arm of the study and a total of 3,300 participants in the study.

Study Type

Interventional

Enrollment (Actual)

3300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Barranquilla, Colombia
        • Hospital Universitario Norte Barranquilla
      • Bogotá, Colombia
        • Clínica SHAIO
      • Bogotá, Colombia
        • Clínica de Occidente
      • Bogotá, Colombia
        • Hospital Universitario La Samaritana
      • Bucaramanga, Colombia
        • Clìnica FOSCAL Internacional
      • Bucaramanga, Colombia
        • Clìnica Foscal_Carlos Ardila lulle
    • Antioquia
      • Medellín, Antioquia, Colombia
        • Hospital IPS Universitaria
      • Medellín, Antioquia, Colombia
        • Hospital San Vicente de Paúl
      • Rionegro, Antioquia, Colombia
        • Hospital San Vicente_RioNegro
    • Atlántico
      • Barranquilla, Atlántico, Colombia
        • Hospital Central Barranquilla
    • Bogotá D.C
      • Bogotá, Bogotá D.C, Colombia, 2356
        • Clínica Palermo
      • Bogotá, Bogotá D.C, Colombia
        • Hospital Militar Central
      • Bogotá, Bogotá D.C, Colombia
        • Hospital San José
    • Caldas
      • Manizales, Caldas, Colombia
        • S.E.S Hospital Universitario de Caldas
    • Cundinamarca
      • Bogotá, Cundinamarca, Colombia
        • Fundación CardioInfantil Instituto de Cardiología
      • Bogotá, Cundinamarca, Colombia
        • Centro Policlínico de Olaya
      • Bogotá, Cundinamarca, Colombia
        • Clinica Nogales
    • Norte De Santander
      • Cúcuta, Norte De Santander, Colombia
        • Hospital Erasmo Meoz
    • Santander
      • Bucaramanga, Santander, Colombia
        • Fundación Cardiovascular Bucaramanga
      • Bucaramanga, Santander, Colombia
        • International Hospital of Colombia -HIC
    • Tolima
      • Ibagué, Tolima, Colombia
        • Hospital Federico Lleras Acosta

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 88 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • The ICU manage adult patients, over 18 years of age, with any type of emphasis (surgical, medical, neurological, or mixed);
  • Patients are admitted in critical condition (with life support);
  • The director accepts the commitment of the care assigned in the randomization (for a period of 3 months).

Exclusion Criteria:

  • Intermediate care units in which patients mobilize themselves.
  • Covid patients or other patients exposed to different mobilization patterns (e.g., 12 hours prone vs 12 supine)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High frequency postural change
Repositioning or rotation of patients hospitalized in bed in intensive care units will be carried out with a frequency interval that we call "high-frequency". It has to be performed on each patient between an interval less than or equal to every 2 hours in a full day (24 hours) (minimum goal of 8-10 in 24 hours subtracting 2 or 4 at night and not alter the circadian cycle). The position must be modified in each postural change to the right lateral, supine, left lateral, supine, or prone position to supine position. The repositioning will be provided until a patient is discharged from ICU, die or begin ambulation. When providing each repositioning, avoid dragging the patient, the shear, and the friction to increase UPP risk. This must be applied to avoiding massage. Patients in any position should use pressure-reducing items such as pillows.
Repositioning of patients hospitalized in bed in intensive care units will be carried out with a frequency interval that we call "high-frequency" to be performed on each patient between an interval between less than or equal to every 2 hours in a full day (24 hours) (minimum goal of 8-10 in 24 hours subtracting 2 or 4 at night and not alter the circadian cycle). The position must be modified in each postural change to right lateral, supine, left lateral, or prone to supine if the position changes every 2 hrs.
Other Names:
  • Repositioning
Active Comparator: Conventional care
Repositioning or rotation of patients hospitalized will be the conventional or usual care. Units in this group are not going to receive any intervention. Will be only observed in their current intervention of repositioning.
Repositioning of patients hospitalized will be performed in the current way it is commonly applied to patients.
Other Names:
  • Control group or usual or current care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence (incidence rata ration) of new pressure ulcers in each Intensive Care Unit (ICU)
Time Frame: " 1 month after admission"
The number of pressure injuries at any stage, new acquired in the ICU after admission per 1,000 patient days in the ICU.
" 1 month after admission"

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk index (HR) and time to event of Pressure ulcers of the patients
Time Frame: "1 month safter admission"
Hazard ratio and tiem to event of PUs of patients included in the repositioning group with the lowest frequency compared to the group of patients included by intervention group in the development of the first PU during their stay in the ICU.
"1 month safter admission"
Security outcomes
Time Frame: "1 month after admission"
Secondary safety outcomes: includes possible complications associated with postural changes: permanent or sporadic changes in ventilatory parameters (hypoxemia), hemodynamic changes (tachycardia, hypertension); events such as acute respiratory failure; or cardiogenic shock, pneumonia.
"1 month after admission"

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Olga L Cortés, PhD, Fundación CardioInfantil Instituto de Cardiología

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2021

Primary Completion (Actual)

December 10, 2023

Study Completion (Actual)

December 10, 2023

Study Registration Dates

First Submitted

October 14, 2020

First Submitted That Met QC Criteria

October 21, 2020

First Posted (Actual)

October 27, 2020

Study Record Updates

Last Update Posted (Actual)

January 22, 2024

Last Update Submitted That Met QC Criteria

January 19, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 844-2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on High frequency postural change

3
Subscribe